For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
In sickness and in health: Te Whatu Ora runs rule over the big trends
In sickness and in health: Te Whatu Ora runs rule over the big trends

Kia ora, please enjoy our Summer Hiatus selection of stories and comment from throughout 2023, curated by our editorial team. This article was first published on 25 September. We will be back from our summer break on 15 January. Happy reading
Chosen by Stephen: The story came out of a Te Whatu Ora presentation in which Gary Jackson spoke about a study that included data on some of the biggest health issues facing the country. Dr Jackson was still finalising the report at the time, but outlined some of his early findings. And despite the fact it covered everything from cancer and diabetes to cardiovascular disease, it wasn’t all bad news
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.